IBRX Earnings

Quarterly EPS
$-0.12
Q3 2024
$-0.08
Q4 2024
$-0.15
Q1 2025
$-0.10
Q2 2025
$-0.07
Q3 2025
$-0.06
Q4 2025
$-0.62
Q1 2026
$-0.22
Q2 2026
Latest Revenue51.2M
Latest Net Income-230390000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2251.2M-230390000+93.9%-120.0%
Q1 2026-$0.6244.2M-632797000+167.6%-313.3%
Q4 2025-$0.0638.3M-61958000+407.0%+25.0%
Q3 2025-$0.0732.1M-67274000+425.1%+41.7%
Q2 2025-$0.1026.4M-92574000+2,423.9%+50.0%
Q1 2025-$0.1516.5M-129666000+41,192.5%+25.0%
Q4 2024-$0.087.6M-59179000+5,333.1%+77.1%
Q3 2024-$0.126.1M-85752000+7,346.3%+36.8%
Q2 2024-$0.201.0M-134584000
Q1 2024-$0.2040.0K-134130000
Q4 2023-$0.35139.0K-233414000
Q3 2023-$0.1982.0K-95642000
ImmunityBio (IBRX) — Earnings